Farak Ali, Shahnaz Alom, Anshul Shakya, Surajit K Ghosh, Udaya P Singh, Hans R Bhat. Arch Pharm (Weinheim) 2022
Times Cited: 1
Times Cited: 1
Times Cited
Times Co-cited
Similarity
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
100
Coronavirus Infections-More Than Just the Common Cold.
Catharine I Paules, Hilary D Marston, Anthony S Fauci. JAMA 2020
Catharine I Paules, Hilary D Marston, Anthony S Fauci. JAMA 2020
100
Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors.
Anshul Shakya, Rupesh V Chikhale, Hans Raj Bhat, Fatmah Ali Alasmary, Tahani Mazyad Almutairi, Surajit Kumar Ghosh, Hassna Mohammed Alhajri, Siham A Alissa, Shuchi Nagar, Md Ataul Islam. Mol Divers 2022
Anshul Shakya, Rupesh V Chikhale, Hans Raj Bhat, Fatmah Ali Alasmary, Tahani Mazyad Almutairi, Surajit Kumar Ghosh, Hassna Mohammed Alhajri, Siham A Alissa, Shuchi Nagar, Md Ataul Islam. Mol Divers 2022
100
100
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.
Haibo Zhang, Josef M Penninger, Yimin Li, Nanshan Zhong, Arthur S Slutsky. Intensive Care Med 2020
Haibo Zhang, Josef M Penninger, Yimin Li, Nanshan Zhong, Arthur S Slutsky. Intensive Care Med 2020
100
Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
Nima Razzaghi-Asl, Ahmad Ebadi, Sara Shahabipour, Danial Gholamin. J Biomol Struct Dyn 2021
Nima Razzaghi-Asl, Ahmad Ebadi, Sara Shahabipour, Danial Gholamin. J Biomol Struct Dyn 2021
100
Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation.
Seketoulie Keretsu, Swapnil P Bhujbal, Seung Joo Cho. Sci Rep 2020
Seketoulie Keretsu, Swapnil P Bhujbal, Seung Joo Cho. Sci Rep 2020
100
Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity.
Justine R Horne, Marie-Claude Vohl. Am J Physiol Endocrinol Metab 2020
Justine R Horne, Marie-Claude Vohl. Am J Physiol Endocrinol Metab 2020
100
Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study.
Md Arif Khan, Shafi Mahmud, A S M Rubayet Ul Alam, Md Ekhtiar Rahman, Firoz Ahmed, Mohammed Rahmatullah. J Biomol Struct Dyn 2021
Md Arif Khan, Shafi Mahmud, A S M Rubayet Ul Alam, Md Ekhtiar Rahman, Firoz Ahmed, Mohammed Rahmatullah. J Biomol Struct Dyn 2021
100
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach.
Sukanth Kumar Enmozhi, Kavitha Raja, Irudhayasamy Sebastine, Jerrine Joseph. J Biomol Struct Dyn 2021
Sukanth Kumar Enmozhi, Kavitha Raja, Irudhayasamy Sebastine, Jerrine Joseph. J Biomol Struct Dyn 2021
100
An in-silico study on selected organosulfur compounds as potential drugs for SARS-CoV-2 infection via binding multiple drug targets.
Liya Thurakkal, Satyam Singh, Rajarshi Roy, Parimal Kar, Sushabhan Sadhukhan, Mintu Porel. Chem Phys Lett 2021
Liya Thurakkal, Satyam Singh, Rajarshi Roy, Parimal Kar, Sushabhan Sadhukhan, Mintu Porel. Chem Phys Lett 2021
100
Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.
Ashish M Kanhed, Dushyant V Patel, Divya M Teli, Nirav R Patel, Mahesh T Chhabria, Mange Ram Yadav. Mol Divers 2021
Ashish M Kanhed, Dushyant V Patel, Divya M Teli, Nirav R Patel, Mahesh T Chhabria, Mange Ram Yadav. Mol Divers 2021
100
Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2.
Gideon A Gyebi, Adegbenro P Adegunloye, Ibrahim M Ibrahim, Oludare M Ogunyemi, Saheed O Afolabi, Olalekan B Ogunro. J Biomol Struct Dyn 2022
Gideon A Gyebi, Adegbenro P Adegunloye, Ibrahim M Ibrahim, Oludare M Ogunyemi, Saheed O Afolabi, Olalekan B Ogunro. J Biomol Struct Dyn 2022
100
Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding.
Miao Gui, Wenfei Song, Haixia Zhou, Jingwei Xu, Silian Chen, Ye Xiang, Xinquan Wang. Cell Res 2017
Miao Gui, Wenfei Song, Haixia Zhou, Jingwei Xu, Silian Chen, Ye Xiang, Xinquan Wang. Cell Res 2017
100
Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach.
Rupesh V Chikhale, Shailendra S Gurav, Rajesh B Patil, Saurabh K Sinha, Satyendra K Prasad, Anshul Shakya, Sushant K Shrivastava, Nilambari S Gurav, Rupali S Prasad. J Biomol Struct Dyn 2021
Rupesh V Chikhale, Shailendra S Gurav, Rajesh B Patil, Saurabh K Sinha, Satyendra K Prasad, Anshul Shakya, Sushant K Shrivastava, Nilambari S Gurav, Rupali S Prasad. J Biomol Struct Dyn 2021
100
Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment.
Muhammad Shehroz, Tahreem Zaheer, Tanveer Hussain. Heliyon 2020
Muhammad Shehroz, Tahreem Zaheer, Tanveer Hussain. Heliyon 2020
100
SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study.
Jamshaid Ahmad, Saima Ikram, Fawad Ahmad, Irshad Ur Rehman, Maryam Mushtaq. Heliyon 2020
Jamshaid Ahmad, Saima Ikram, Fawad Ahmad, Irshad Ur Rehman, Maryam Mushtaq. Heliyon 2020
100
In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis.
Pratik Das, Ranabir Majumder, Mahitosh Mandal, Piyali Basak. J Biomol Struct Dyn 2021
Pratik Das, Ranabir Majumder, Mahitosh Mandal, Piyali Basak. J Biomol Struct Dyn 2021
100
In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria.
Imane Abdelli, Faiçal Hassani, Sohayb Bekkel Brikci, Said Ghalem. J Biomol Struct Dyn 2021
Imane Abdelli, Faiçal Hassani, Sohayb Bekkel Brikci, Said Ghalem. J Biomol Struct Dyn 2021
100
Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies.
Atala B Jena, Namrata Kanungo, Vinayak Nayak, G B N Chainy, Jagneshwar Dandapat. Sci Rep 2021
Atala B Jena, Namrata Kanungo, Vinayak Nayak, G B N Chainy, Jagneshwar Dandapat. Sci Rep 2021
100
In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor.
Lei Wen, Kaiming Tang, Kenn Ka-Heng Chik, Chris Chun-Yiu Chan, Jessica Oi-Ling Tsang, Ronghui Liang, Jianli Cao, Yaoqiang Huang, Cuiting Luo, Jian-Piao Cai,[...]. Int J Biol Sci 2021
Lei Wen, Kaiming Tang, Kenn Ka-Heng Chik, Chris Chun-Yiu Chan, Jessica Oi-Ling Tsang, Ronghui Liang, Jianli Cao, Yaoqiang Huang, Cuiting Luo, Jian-Piao Cai,[...]. Int J Biol Sci 2021
100
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
100
Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis.
Satyam Singh, Md Fulbabu Sk, Avinash Sonawane, Parimal Kar, Sushabhan Sadhukhan. J Biomol Struct Dyn 2021
Satyam Singh, Md Fulbabu Sk, Avinash Sonawane, Parimal Kar, Sushabhan Sadhukhan. J Biomol Struct Dyn 2021
100
Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach.
Ranabir Majumder, Mahitosh Mandal. J Biomol Struct Dyn 2022
Ranabir Majumder, Mahitosh Mandal. J Biomol Struct Dyn 2022
100
Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.
Anamika Basu, Anasua Sarkar, Ujjwal Maulik. Sci Rep 2020
Anamika Basu, Anasua Sarkar, Ujjwal Maulik. Sci Rep 2020
100
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
100
In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.
T Joshi, T Joshi, P Sharma, S Mathpal, H Pundir, V Bhatt, S Chandra. Eur Rev Med Pharmacol Sci 2020
T Joshi, T Joshi, P Sharma, S Mathpal, H Pundir, V Bhatt, S Chandra. Eur Rev Med Pharmacol Sci 2020
100
Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches.
Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Tyagi, Arvind Bhushan, Madhu Rathore. J Biomol Struct Dyn 2021
Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Tyagi, Arvind Bhushan, Madhu Rathore. J Biomol Struct Dyn 2021
100
In silico assessment of potential leads identified from Bauhinia rufescens Lam. as α-glucosidase and α-amylase inhibitors.
Wadah Osman, Esraa M O A Ismail, Shaza W Shantier, Mona S Mohammed, Ramzi A Mothana, Abdelkhalig Muddathir, Hassan S Khalid. J Recept Signal Transduct Res 2021
Wadah Osman, Esraa M O A Ismail, Shaza W Shantier, Mona S Mohammed, Ramzi A Mothana, Abdelkhalig Muddathir, Hassan S Khalid. J Recept Signal Transduct Res 2021
100
Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study.
Vanderlan Nogueira Holanda, Elton Marlon de Araújo Lima, Welson Vicente da Silva, Rafael Trindade Maia, Rafael de Lima Medeiros, Arabinda Ghosh, Vera Lúcia de Menezes Lima, Regina Celia Bressan Queiroz de Figueiredo. J Biomol Struct Dyn 2022
Vanderlan Nogueira Holanda, Elton Marlon de Araújo Lima, Welson Vicente da Silva, Rafael Trindade Maia, Rafael de Lima Medeiros, Arabinda Ghosh, Vera Lúcia de Menezes Lima, Regina Celia Bressan Queiroz de Figueiredo. J Biomol Struct Dyn 2022
100
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants.
Muhammad Tahir Ul Qamar, Safar M Alqahtani, Mubarak A Alamri, Ling-Ling Chen. J Pharm Anal 2020
Muhammad Tahir Ul Qamar, Safar M Alqahtani, Mubarak A Alamri, Ling-Ling Chen. J Pharm Anal 2020
100
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease.
Hylemariam Mihiretie Mengist, Tebelay Dilnessa, Tengchuan Jin. Front Chem 2021
Hylemariam Mihiretie Mengist, Tebelay Dilnessa, Tengchuan Jin. Front Chem 2021
100
Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
Zeynab Fakhar, Bahar Faramarzi, Severina Pacifico, Shadab Faramarzi. J Biomol Struct Dyn 2021
Zeynab Fakhar, Bahar Faramarzi, Severina Pacifico, Shadab Faramarzi. J Biomol Struct Dyn 2021
100
Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme.
Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah, Khalid Mashay Al-Anazi. J King Saud Univ Sci 2020
Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah, Khalid Mashay Al-Anazi. J King Saud Univ Sci 2020
100
Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study.
Trina Ekawati Tallei, Sefren Geiner Tumilaar, Nurdjannah Jane Niode, Fatimawali, Billy Johnson Kepel, Rinaldi Idroes, Yunus Effendi, Shahenur Alam Sakib, Talha Bin Emran. Scientifica (Cairo) 2020
Trina Ekawati Tallei, Sefren Geiner Tumilaar, Nurdjannah Jane Niode, Fatimawali, Billy Johnson Kepel, Rinaldi Idroes, Yunus Effendi, Shahenur Alam Sakib, Talha Bin Emran. Scientifica (Cairo) 2020
100
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.
Vincent J Munster, Marion Koopmans, Neeltje van Doremalen, Debby van Riel, Emmie de Wit. N Engl J Med 2020
Vincent J Munster, Marion Koopmans, Neeltje van Doremalen, Debby van Riel, Emmie de Wit. N Engl J Med 2020
100
In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme.
Shilpa Chatterjee, Arindam Maity, Suchana Chowdhury, Md Ataul Islam, Ravi K Muttinini, Debanjan Sen. J Biomol Struct Dyn 2021
Shilpa Chatterjee, Arindam Maity, Suchana Chowdhury, Md Ataul Islam, Ravi K Muttinini, Debanjan Sen. J Biomol Struct Dyn 2021
100
Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor.
Manish Kumar Tripathi, Pushpendra Singh, Sujata Sharma, Tej P Singh, A S Ethayathulla, Punit Kaur. J Biomol Struct Dyn 2021
Manish Kumar Tripathi, Pushpendra Singh, Sujata Sharma, Tej P Singh, A S Ethayathulla, Punit Kaur. J Biomol Struct Dyn 2021
100
In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly.
Rajan Rolta, Rohitash Yadav, Deeksha Salaria, Shubham Trivedi, Mohammad Imran, Anuradha Sourirajan, David J Baumler, Kamal Dev. J Biomol Struct Dyn 2021
Rajan Rolta, Rohitash Yadav, Deeksha Salaria, Shubham Trivedi, Mohammad Imran, Anuradha Sourirajan, David J Baumler, Kamal Dev. J Biomol Struct Dyn 2021
100
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.
Qihui Wang, Yanfang Zhang, Lili Wu, Sheng Niu, Chunli Song, Zengyuan Zhang, Guangwen Lu, Chengpeng Qiao, Yu Hu, Kwok-Yung Yuen,[...]. Cell 2020
Qihui Wang, Yanfang Zhang, Lili Wu, Sheng Niu, Chunli Song, Zengyuan Zhang, Guangwen Lu, Chengpeng Qiao, Yu Hu, Kwok-Yung Yuen,[...]. Cell 2020
100
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).
Catrin Sohrabi, Zaid Alsafi, Niamh O'Neill, Mehdi Khan, Ahmed Kerwan, Ahmed Al-Jabir, Christos Iosifidis, Riaz Agha. Int J Surg 2020
Catrin Sohrabi, Zaid Alsafi, Niamh O'Neill, Mehdi Khan, Ahmed Kerwan, Ahmed Al-Jabir, Christos Iosifidis, Riaz Agha. Int J Surg 2020
100
The Cambridge Structural Database in retrospect and prospect.
Colin R Groom, Frank H Allen. Angew Chem Int Ed Engl 2014
Colin R Groom, Frank H Allen. Angew Chem Int Ed Engl 2014
100
In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis.
Azza Hanif Harisna, Rizky Nurdiansyah, Putri Hawa Syaifie, Dwi Wahyu Nugroho, Kurniawan Eko Saputro, Firdayani, Chandra Dwi Prakoso, Nurul Taufiqu Rochman, Nurwenda Novan Maulana, Alfian Noviyanto,[...]. Biochem Biophys Rep 2021
Azza Hanif Harisna, Rizky Nurdiansyah, Putri Hawa Syaifie, Dwi Wahyu Nugroho, Kurniawan Eko Saputro, Firdayani, Chandra Dwi Prakoso, Nurul Taufiqu Rochman, Nurwenda Novan Maulana, Alfian Noviyanto,[...]. Biochem Biophys Rep 2021
100
Mechanisms of coronavirus cell entry mediated by the viral spike protein.
Sandrine Belouzard, Jean K Millet, Beth N Licitra, Gary R Whittaker. Viruses 2012
Sandrine Belouzard, Jean K Millet, Beth N Licitra, Gary R Whittaker. Viruses 2012
100
Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19.
Ananta Swargiary, Shafi Mahmud, Md Abu Saleh. J Biomol Struct Dyn 2022
Ananta Swargiary, Shafi Mahmud, Md Abu Saleh. J Biomol Struct Dyn 2022
100
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors.
Vladimir Uladzimir Ladziata, Peter W Glunz, Yan Zou, Xiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, Daniel L Cheney, Anzhi Wei, Joseph M Luettgen, Timothy M Harper,[...]. Bioorg Med Chem Lett 2016
Vladimir Uladzimir Ladziata, Peter W Glunz, Yan Zou, Xiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, Daniel L Cheney, Anzhi Wei, Joseph M Luettgen, Timothy M Harper,[...]. Bioorg Med Chem Lett 2016
100
Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective.
Oludare M Ogunyemi, Gideon A Gyebi, Abdo A Elfiky, Saheed O Afolabi, Olalekan B Ogunro, Adegbenro P Adegunloye, Ibrahim M Ibrahim. Antivir Chem Chemother 2020
Oludare M Ogunyemi, Gideon A Gyebi, Abdo A Elfiky, Saheed O Afolabi, Olalekan B Ogunro, Adegbenro P Adegunloye, Ibrahim M Ibrahim. Antivir Chem Chemother 2020
100
Processing of the human coronavirus 229E replicase polyproteins by the virus-encoded 3C-like proteinase: identification of proteolytic products and cleavage sites common to pp1a and pp1ab.
J Ziebuhr, S G Siddell. J Virol 1999
J Ziebuhr, S G Siddell. J Virol 1999
100
Potential for global spread of a novel coronavirus from China.
Isaac I Bogoch, Alexander Watts, Andrea Thomas-Bachli, Carmen Huber, Moritz U G Kraemer, Kamran Khan. J Travel Med 2020
Isaac I Bogoch, Alexander Watts, Andrea Thomas-Bachli, Carmen Huber, Moritz U G Kraemer, Kamran Khan. J Travel Med 2020
100
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.
M Donoghue, F Hsieh, E Baronas, K Godbout, M Gosselin, N Stagliano, M Donovan, B Woolf, K Robison, R Jeyaseelan,[...]. Circ Res 2000
M Donoghue, F Hsieh, E Baronas, K Godbout, M Gosselin, N Stagliano, M Donovan, B Woolf, K Robison, R Jeyaseelan,[...]. Circ Res 2000
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.